Immuron Ltd Owned Ateria Health Launches Juvia in Australia
Portfolio Pulse from Benzinga Newsdesk
Immuron Limited, an Australian biopharmaceutical company listed on NASDAQ as IMRN, has announced that its subsidiary, Ateria Health Australia, has launched Juvia in Australia. Immuron holds a 17.5% shareholding in Ateria, a UK-based biotech company that develops and distributes health supplements.
July 11, 2023 | 10:06 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Immuron's subsidiary, Ateria Health, has launched a new product in Australia. This could potentially increase Immuron's revenues due to its 17.5% stake in Ateria.
The launch of a new product typically leads to increased revenues for the company, especially if the product is successful in the market. Given Immuron's significant stake in Ateria, it stands to benefit from the revenues generated by the new product.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100